AssetMark Inc’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.22M Sell
79,943
-2,155
-3% -$80.6K 0.01% 775
2025
Q4
$2.86M Buy
82,098
+17,372
+27% +$1.36M 0.01% 774
2025
Q3
$5.38M Buy
64,726
+2,961
+5% +$214K 0.01% 615
2025
Q2
$4.53M Sell
61,765
-9,225
-13% -$669K 0.01% 606
2025
Q1
$8.11M Buy
70,990
+14,413
+25% +$877K 0.02% 396
2024
Q4
$2.85M Sell
56,577
-6,734
-11% -$353K 0.01% 634
2024
Q3
$2.93M Buy
63,311
+1,235
+2% +$43.9K 0.01% 570
2024
Q2
$2.02M Buy
62,076
+5,100
+9% +$140K 0.01% 615
2024
Q1
$1.44M Buy
56,976
+875
+2% +$20.7K ﹤0.01% 648
2023
Q4
$1.82M Buy
56,101
+38,674
+222% +$1.06M 0.01% 551
2023
Q3
$475K Sell
17,427
-27,149
-61% -$786K ﹤0.01% 763
2023
Q2
$992K Buy
44,576
+2,561
+6% +$58.9K ﹤0.01% 613
2023
Q1
$910K Buy
42,015
+3,325
+9% +$72.9K ﹤0.01% 617
2022
Q4
$786K Buy
38,690
+1,089
+3% +$27.3K ﹤0.01% 633
2022
Q3
$964K Buy
37,601
+620
+2% +$16.6K ﹤0.01% 519
2022
Q2
$879K Buy
36,981
+3,390
+10% +$73.9K ﹤0.01% 525
2022
Q1
$756K Sell
33,591
-4,215
-11% -$89.7K ﹤0.01% 537
2021
Q4
$749K Sell
37,806
-26,068
-41% -$529K ﹤0.01% 464
2021
Q3
$1.26M Buy
63,874
+6,315
+11% +$132K 0.01% 374
2021
Q2
$1.27M Buy
57,559
+29,258
+103% +$651K 0.01% 363
2021
Q1
$673K Buy
28,301
+2,258
+9% +$60.3K ﹤0.01% 409
2020
Q4
$681K Sell
26,043
-21,540
-45% -$454K ﹤0.01% 393
2020
Q3
$828K Buy
47,583
+38,501
+424% +$614K 0.01% 348
2020
Q2
$153K Buy
+9,082
New +$128K ﹤0.01% 526

Other funds holding CORT